StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$5.69−0.53 (-8.52%)

Close on Nov 17, 2026Market cap $37.05MP/E –Yield –

Tevogen total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tevogen's total debt was $0 at Dec 31, 2022. For fiscal 2022 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0–

More Tevogen figures

See a number that looks wrong?